Previous 10 | Next 10 |
Pear is working with select telehealth providers to put recovery in the hands of those seeking help remotely Pear’s first telehealth offering is with PursueCare, a leading telehealth addiction treatment provider, to offer patients an end-to-end virtual continuum o...
Pear delivered well for the FY despite only being a post-revenue company for part of it. Covered lives are developing fast, and prescription numbers have just started to ramp. 2022 will be a full year of performance, and the company is guiding to sharp increases in prescriptions. ...
Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs), today announced the company will participate in the Credit Suisse The Investor Landscape: Hidden Gems Conference on Thursda...
Gainers: Adagio Therapeutics (ADGI) +47%. Insignia Systems (ISIG) +26%. Romeo Power (RMO) +24%. Vir Biotechnology (VIR) +20%. TMC the metals company (TMC) +19%. Arhaus (ARHS) +19%. Ambac Financial Group (AMBC) +18%. Pear Therapeutics (PEAR) +17%. Vyant Bio (VYNT) +16%. Sportradar (SRAD) +16%....
Pear Therapeutics, Inc. (PEAR) Q4 2021 Earnings Conference Call March 28, 2022 16:30 ET Corporate Participants Meera Murphy - Senior Director of Corporate Communications Corey McCann - President & CEO Chris Guiffre - Chief Financial Officer and Chief Operating Officer Erin Brenner - Chief...
press release (NASDAQ:PEAR): FY GAAP EPS of -$0.57 beats by $2.30. Revenue of $4.2M (-54.8% Y/Y) misses by $0.21M. For further details see: GAAP EPS of -$0.57 beats by $2.30, revenue of $4.2M misses by $0.21M
$4.2 million total revenue for the full year 2021 2021 highlights include Current Procedural Terminology (CPT) codes for prescribers, first state Medicaid coverage decision, two major PBM formulary additions, more than 30 organizations providing access, and 9-month HEOR ...
Pear Therapeutics (NASDAQ:PEAR) said its PearConnect platform will be available to healthcare providers in the Epic App Orchard Gallery. The company said this will allow healthcare providers to access the platform to remotely monitor patients who have been prescribed its FDA-authorized p...
PearConnect ™ platform for prescription digital therapeutics (PDTs) is now available for providers in the Epic App Orchard Gallery Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescrip...
Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs) , today announced an agreement with SoftBank Corp. (“SoftBank”) to develop a Japanese-language digital ther...